Teleflex (NYSE:TFX) Issues Earnings Results

Teleflex (NYSE:TFX) released its quarterly earnings data on Thursday. The medical technology company reported $3.89 earnings per share for the quarter, topping analysts’ consensus estimates of $3.86 by $0.03, Zacks reports. The company had revenue of $795.40 million for the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Teleflex updated its FY 2025 guidance to 13.950-14.350 EPS.

Teleflex Trading Down 4.7 %

Shares of TFX stock opened at $132.58 on Friday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $6.16 billion, a price-to-earnings ratio of 26.36, a PEG ratio of 1.73 and a beta of 1.16. The firm has a 50-day moving average price of $175.44 and a 200 day moving average price of $205.04. Teleflex has a twelve month low of $130.60 and a twelve month high of $249.90.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 1.03%. The ex-dividend date of this dividend is Friday, March 7th. Teleflex’s payout ratio is 27.04%.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the stock. Royal Bank of Canada lowered shares of Teleflex from an “outperform” rating to a “sector perform” rating and lowered their target price for the stock from $220.00 to $155.00 in a research report on Friday. Truist Financial lowered their target price on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Wells Fargo & Company lowered their price objective on shares of Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research report on Friday. Mizuho reduced their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, November 1st. Finally, Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday. Nine equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $196.83.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.